H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 22.1 HKD 1.14%
Market Cap: 131.2B HKD

Intrinsic Value

The intrinsic value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 17.89 HKD. Compared to the current market price of 22.1 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
17.89 HKD
Overvaluation 19%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hansoh Pharmaceutical Group Company Ltd

Hansoh Pharmaceutical Group Company Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Hansoh Pharmaceutical Group Company Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
CN
Pharmaceuticals
Market Cap
131.1B HKD
IPO
Jun 14, 2019
CN
Pharmaceuticals
Market Cap
131.1B HKD
IPO
Jun 14, 2019
Price
HK$false
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hansoh Pharmaceutical Group Company Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Hansoh Pharmaceutical Group Company Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hansoh Pharmaceutical Group Company Ltd

Current Assets 27.4B
Cash & Short-Term Investments 23.4B
Receivables 3.2B
Other Current Assets 885.8m
Non-Current Assets 4.2B
Long-Term Investments 702.3m
PP&E 3.3B
Intangibles 245.3m
Efficiency

Free Cash Flow Analysis
Hansoh Pharmaceutical Group Company Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hansoh Pharmaceutical Group Company Ltd

Revenue
12.3B CNY
Cost of Revenue
-1.1B CNY
Gross Profit
11.2B CNY
Operating Expenses
-6.1B CNY
Operating Income
5.1B CNY
Other Expenses
-685m CNY
Net Income
4.4B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hansoh Pharmaceutical Group Company Ltd's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional ROIC
75/100
Profitability
Score

Hansoh Pharmaceutical Group Company Ltd's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hansoh Pharmaceutical Group Company Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Hansoh Pharmaceutical Group Company Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hansoh Pharmaceutical Group Company Ltd

Wall Street analysts forecast Hansoh Pharmaceutical Group Company Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hansoh Pharmaceutical Group Company Ltd is 25.29 HKD with a low forecast of 20.06 HKD and a high forecast of 33.6 HKD.

Lowest
Price Target
20.06 HKD
9% Downside
Average
Price Target
25.29 HKD
14% Upside
Highest
Price Target
33.6 HKD
52% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hansoh Pharmaceutical Group Company Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Hansoh Pharmaceutical Group Company Ltd stock?

The intrinsic value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 17.89 HKD.

Is Hansoh Pharmaceutical Group Company Ltd stock undervalued or overvalued?

Compared to the current market price of 22.1 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 19%.

Back to Top